McCoy Linda C, Wehler Carolyn J, Rich Sharron E, Garcia Raul I, Miller Donald R, Jones Judith A
Center for Health Quality, Outcomes and Economic Research, Edith Nourse Rogers Memorial Veterans Hospital, 200 Springs Road (152), Bedford, MA 01730, USA.
J Am Dent Assoc. 2008 Feb;139(2):178-83. doi: 10.14219/jada.archive.2008.0134.
The authors report adverse events (AEs) related to the use of chlorhexidine gluconate mouthrinse in a clinical trial of the efficacy of periodontal treatment in older adults with diabetes.
Participants were U.S. veterans with uncontrolled diabetes (hemoglobin A(1c) value > or =8.5 percent) and periodontal disease. Treatment included periodontal scaling, 0.12 percent chlorhexidine lavage during ultrasonic scaling and use of chlorhexidine mouthrinse at home.
Forty-four (31 percent) of 140 subjects reported having AEs. Most common were taste changes and tooth staining, sore mouth and/or throat, tongue irritation and wheezing/shortness of breath; the latter was reported more commonly before chlorhexidine use than after. Only body mass index greater than 30 was significantly related to AEs.
AEs are common among subjects using chlorhexidine mouthrinse. Most AEs (taste change and staining) were resolved easily by subjects' discontinuing mouthrinse use and receiving dental prophylaxis. No serious AEs were reported.
Clinicians should advise patients using chlorhexidine mouthrinse of possible side effects. If necessary, patients should discontinue mouthrinse use and obtain medical care. Careful monitoring of AEs in patients using chlorhexidine is warranted.
作者报告了在一项针对老年糖尿病患者牙周治疗疗效的临床试验中,与使用葡萄糖酸洗必泰漱口水相关的不良事件(AE)。
参与者为患有未控制糖尿病(糖化血红蛋白值≥8.5%)和牙周病的美国退伍军人。治疗包括牙周洁治、超声洁治期间使用0.12%洗必泰冲洗以及在家使用洗必泰漱口水。
140名受试者中有44名(31%)报告发生了不良事件。最常见的是味觉改变和牙齿染色、口腔和/或喉咙疼痛、舌头刺激以及喘息/呼吸急促;后者在使用洗必泰之前比之后更常被报告。只有体重指数大于30与不良事件显著相关。
使用洗必泰漱口水的受试者中不良事件很常见。大多数不良事件(味觉改变和染色)通过受试者停止使用漱口水并接受牙齿预防措施后很容易得到解决。未报告严重不良事件。
临床医生应告知使用洗必泰漱口水的患者可能出现的副作用。如有必要,患者应停止使用漱口水并寻求医疗护理。对使用洗必泰的患者进行不良事件的仔细监测是有必要的。